Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: Recent findings from in vivo microdialysis studies

Fundamental and Clinical Pharmacology

Volumn 10, Issue 1, 1996, Pages 16-27

  Gardier, A M ^a   Malagie I ^a   Trillat, A C ^a   Jacquot, C ^a   Artigas, F ^b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

5 HT1A autoreceptors ; Antidepressant drugs ; In vivo microdialysis; Serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN AGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; CITALOPRAM; CLOMIPRAMINE; CLORGYLINE; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PINDOLOL; SEROTONIN 1A RECEPTOR; SERTRALINE; TRANYLCYPROMINE;

ANIMAL; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MICRODIALYSIS; PHYSIOLOGY; RAT; REVIEW; ANIMAL CELL; ANIMAL TISSUE; DEPRESSION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SYNAPSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; MICRODIALYSIS; RATS; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0029670276     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00145.x     Document Type: Review

References (88)

1. Adell A, Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 1991;343:237-44
2. Adell A, Carceller A, Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: effects of 8-hydroxy-2(-di-n-propylamino)tetralin. J Neurochem 1993;60:1673-81
3. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of patients with depression treated with serotonin reuptake inhibitors. Arch gen Psychiatry 1994; 51:248-51
4. Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 1993;14:262-3
5. Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA 1986;255:357-60
6. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978;179:641-68
7. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 1993;15:243-5
8. Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur J Pharmacol 1992;229:101-3
9. 1A antagonist pindolol. In: Louilot A, Durkin T, Spampinato U, Cador M, eds. Monitoring Molecules in Neuroscience. Proceedings of the 6th International Conference on in vivo Methods 1994;209-10
10. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 1995;15:217-22
11. Blier P, De Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987;7:24S-35S
12. Blier P, De Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 1994; 15:220-6
13. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1987;1:470-80
14. Blier P, de Montigny C. Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 1983; 3:1270-8
15. Blier P, Lista A, De Montigny C. Differential properties of presynaptic and postsynaptic 5-hydroxytryptamine(1A) receptors in the dorsal raphe and hippocampus. 1. Effect of spiperone. J Pharmacol Exp Ther 1993;265:7-15
16. 1A receptors in the rat brain. Soc Neurosci Abst 1994;20:1540
17. Bosker FJ, Klompmakers A, Westenberg HGM. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 1995;34:501-8
18. Bosker F, Klompmakers A, Westenberg H. Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino) tetralin and is sensitive to tetrodotoxin. J Neurochem 1994;63:2165-71
19. Carboni E, Di Chiara G. Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience 1989;32:367-445
20. Celada P, Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. Naunyn-Schmiedeberg's Arch Pharmacol 1993;347:583-90
21. Chaput Y, de Montigny C, Blier P. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 1986;333:342-48
22. Cortes R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography af antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience 1988;27:473-96
23. Dailey JW, Yan QS, Mishral PK, Burger RL, Jobe PC. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats. J Pharmacol Exp Ther 1992;260:533-40
24. De Montigny C, Chaput Y, Blier P. Classical and novel targets for antidepressant drugs. New pharmacological approaches to the therapy of depressive disorders. Int Acad Biomed Drug Res 1993;5:8-17
25. Deakin JFW, Graeff FG, Guimaraes FS. Clinical implication of microdialysis findings. Trends Pharmacol Sci 1993;14:263
26. Dechant KL, Clissold SP. Paroxetine. A review of its pharmacodynamic and pharamcokinetic properties, and therapeutic potential in depressive illness. Drugs 1991;41:225-53
27. Delgado JMR, Defeudis FV, Roth RH, Ryugo DK, Mitruka BM. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 1972;198: 9-21
28. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411-8
29. Descarries L, Watkins KC, Garcia S, Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol 1982;207:239-54
30. Ferrer A, Artigas F. Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. Eur J Pharmacol 1994;263:227-34
31. Fuller RW. Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 1994;55:163-7
32. Fuxe K, Calza L, Benfenati F, Zini I, Agnati L. Quantitative autoradiographic localization of [3H]imipramine binding sites in the brain of the rat: relationship to ascending 5-hydroxy-tryptamine neuron systems. Proc Natl Acad Sci USA 1983;80:3836-40
33. Gardier AM, Wurtman RJ. Persistent blockade of potassium-evoked serotonin release from rat frontocortical terminals after fluoxetine administration. Brain Res 1991;540:325-30
34. Gardier AM, Kaakkola S, Erfurth A, Wurtman RJ. Effects of methiothepin on changes in brain serotonin release induced by repeated administration of high doses of anorectic serotoninergic drugs. Brain Res 1992;588:67-74
35. Gardier AM, Lepoul E, Chanut E., Trouvin JH, Jacquot C. Changes in dopamine metabolism in rat forebrain regions after cessation of long-term fluoxetine treatment: correlation with brain concentrations of fluoxetine and norfluoxetine. Life Sci 1994;54:PL51-56
36. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT. Br J Pharmacol 1995;115:1064-70
37. Guan XM, McBride WJ. Fluoxetine increases the extracellular levels of serotonin in the nucleus accumbens. Brain Res Bull 1988;21:43-6
38. 1A receptors: pharmacological, biochemical, functional and regulatory properties. Ann NY Acad Sci 1990;600:114-31
39. Heninger GR, Charney DS. Mechanism of action of antidepressant treatment: implication for the etiology and treatment of depressive disorders. In: Meltzer H, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987;535-44
40. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmied Arch Pharmacol 1988;338:463-71
41. Hjorth S, Suchowski CS, Galloway MP. Evidence for 5-HT autoreceptor-mediated, nerve impulse-independent, control of 5-HT synthesis in the rat brain. Synapse 1995;19:170-6
42. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminals output of 5-HT in vivo: a microdialysis study. J Neurochem 1993;60:776-9
43. 1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 1994; 33:331-4
44. Hoyer D, Clarke DE, Fozard JR et al. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994;46: 157-203
45. Hrdina PD, Foy B, Hepner A, Summers RJ. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 1990;252:410-8
46. 2 receptors in rat brain- An Autoradiographic Study. Synapse 1993;14:324-31
47. Hutson PM, Sarna GS, O'Connell MT, Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci Lett 1989;100:276-80
48. Hyttel J, Overo KF, Arnt J. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology 1984; 83:20-7
49. Imai H, Sieindler DA, Kitai ST. The organization of divergent axonal projections from the midbrain raphe nuclei ih the rat. J Comp Neurol 1986;243:363-80
50. Invernizzi R, Belli S, Samanin R Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphé prevents the drug's effect in the frontal cortex. Brain Res 1992;584:322-4
51. 1A receptors. Eur J Pharmacol 1994;260:243-6
52. Invernizzi R, Carli M, Di Clemente A, Samanin R. Administration of 8-hydroxy-2-(Di-n-propylamino)tetralin in raphe nuclei dorsalis and medianus reduces serotonin synthesis in rat brain: differences in potency and regional sensitivity. J Neurochem 1991;56:243-7
53. 1A autoreceptors by chronic administration of 8-OH-DPAT. Neuropharmacology 1992;31:1073-6
54. Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 1995;274:866-76
55. Malagié I, Trillat AC, Jacquot C, Gardier AM. Effects of acute fluoxetine on extracellular serotonin concentrations in the raphe: an in vivo microdialysis study. Eur J Pharmacol 1995;286:213-7
56. Malagié I, Jacquot C, Gardier AM. Enhanced efficacy of 5-HT neurotransmission at frontocortical nerve terminals after chronic administration of fluoxetine in rats: an in vivo microdialysis study of the evoked release by electrical stimulation of the dorsal raphe nucleus. In: Louilot A, Durkin T, Spampinato U, Cador M, eds. Monitoring Molecules in Neuroscience. Proceedings of the 6th International Conference on in vivo Methods, 1994;205-6
57. Marsden CA, Conti J, Strope E, Curzon G, Adams RN. Monitoring 5-hydroxytryptamine release in the brain of the freely moving unanesthetized rat using in vivo voltammetry. Brain Res 1979;171:85-99
58. Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994;9:47-53
59. Moret C, Briley M. In vitro and in vivo activity of 1-(1-naphtyl)piperazine at terminal 5-HT autoreceptors in guinea-pig brain. Naunyn-Schmied Arch Pharmacol 1995;351:377-84
60. Moret C, Briley M. The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism. J Psychopharmacol 1993;7:331-7
61. Nalepa I, Vetulani J. Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-Hydroxytryptamine uptake inhibitor citalopram. J Neurochem 1993;60:2029-35
62. O'Heam E, Molliver ME. Organization of raphe cortical projections in rat: a quantitative retrograde study. Brain Res Bull 1984;13:709-26
63. Oleskevich S, Descarries L, Watkins KC, Seguela PI, Daszuta A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience 1991; 42:777-91
64. Oleskevich S, Descarries L. Quantified distribution of the serotonin innervation in adult rat hippocampus. Neuroscience 1990;34:19-33
65. Palvimaki EP, Laakso A, Kuoppamaki M, Syvalahti E, Hietala J. Up-regulation of beta(1)-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments. Psychopharmacology 1991;15:543-6
66. 1A receptors in the human brain: an autoradiographic study. IUPH'AR Satellite Meeting on Serotonin 1994;3:99 (Abstract)
67. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 1980;210:88-90
68. Perry KW, Fuller RW. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sci 1992;50:1683-90
69. Perry KW, Fuller RW. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan. J Pharm Pharmacol 1993;45:759-61
70. Pinder RM, Wieringa JH. Third-generation antidepressants. Medicinal Res Rev 1993;13:259-325
71. Pineyro G, Blier P, Dennis T, De Montigny C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 1994;14:3036-47
72. Romero L, Celada P, Artigas F. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus. Eur J Pharmacol 1994;265:103-6
73. Rutter JJ, Auerbach SB. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J Pharmacol Exp Ther 1993;265:1319-24
74. Rutter JJ, Gundlah C, Auerbach SB. Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine. Neurosci Let 1994; 171:183-6
75. Rutter JJ, Gundlah C, Auerbach SB. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation. Synapse 1995;20:225-33
76. Sabol KE, Richards JB, Seiden LS. Fluoxetine attenuates the DL-fenfluramine-induced increase in extracellular serotonin as measured by in vivo microdialysis. Brain Res 1992; 585:421-4
77. Sharp T, Bramwell SR, Grahame-Smith DG. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 1989;96:283-90
78. 1A receptor agonists on 5-HT release in rat brain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 1993;348:339-46
79. Singh A, Lucki I. Effect of chronic fluoxetine administration on hippocampal 5-HT concentrations as measured by in vivo microdialysis. Soc Neurosci Abst 1994;20:294
80. Sinton CM, Fallon SL. Electrophysiological evidence for differentiation between subtypes of the 5-HT1 receptor. Eur J Pharmacol 1988;157:173-81
81. 1A receptor agonist, buspirone, after prolonged chronic administration. Eur J Pharmacol 1993; 239:69-73
82. 1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 1990;2:1144-54
83. 1B agonists. Synapse 1987;1:3-9
84. Ungerstedt U. Measurement of neurotransmitter release in vivo. In: Marsden CA, ed. Methods in the Neurosciences. New York: Wiley-Interscience Publication, 1984;vol. 6:81-106
85. 1A binding sites on serotonin containing neurons in the raphe dorsal is and raphe centralis nuclei of the rat brain. Neurochem Int 1985;7:1061-72
86. Wiklund L, Leger L, Person M. Monoamine cell distribution in the cat brain, a fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J Comp Neurol 1981;203:613-47
87. Wozniak K, Pert A, Linnoila M. Alterations in raphe and frontal cortex serotonin overflow following focal and systemic administration of serotonin. Soc Neurosci Abst 1992; 18:1525
88. Zifa E, Fillion G. 5-hydroxytryptamine receptors. Pharmacol Rev 1992;44:401-58